Skip to main content

Sym Financial Corp

SEC CIK
0000764739
Latest filing
Aug 4, 2026

NBIX holding history

Neurocrine Biosciences Inc in every 13F filed by Sym Financial Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NBIX overviewAll 13F holders of NBIXFull Q2 2026 holdings

Shares (Q2 2026)
1,207
Value
$203.4K
% of portfolio
<0.1%
Quarters held
4
Since Q3 2025
Holdings of NBIX by Sym Financial Corp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,207$203.4K<0.1%−735−37.8%ReducedHolders
Q1 20261,942$255.8K<0.1%−97−4.8%ReducedHolders
Q4 20252,039$289.2K<0.1%+281+16.0%AddedHolders
Q3 20251,758$246.8K<0.1%+1,758NewHolders